Building LGBTQ Community-Driven Research
Washington, DC has the highest lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) population (10%) among states in the nation. Beginning in August 2016, the GW Cancer Center is working to better understand the health concerns of LGBTQ individuals in DC in order to develop research that will compare the effectiveness of interventions designed to reduce risk, alleviate disparities and improve cancer-related patient-reported outcomes. This work is supported by a contract from the Patient-Centered Outcomes Research Institute through the Pipeline to Proposals mechanism.
Addressing Barriers to Care
In 2015, the GW Cancer Institute will create a three-part evaluation tool to measure impact and value of patient navigation in clinical practice. This research study is supported by a grant from Genentech.
Evaluating Cancer Survivorship Care Models
The goal of this project is to identify and compare the effectiveness of care delivery models for cancer survivors who have completed active treatment, with a focus on survivors of breast, prostate and colorectal cancers. The results will provide valuable information to cancer survivors and their families, clinicians, accrediting bodies, payers and other stakeholders in making decisions about post-treatment care.
Tobacco Cessation at Whitman-Walker Health
The GW Cancer Institute has partnered with Whitman-Walker Health to conduct an evaluation of tobacco cessation services to targeted populations in DC through the American Lung Association curriculum Freedom from Smoking. This research will help tailor future tobacco cessation interventions to increase effectiveness. The project is funded by a Community Health Administration grant from the District of Columbia Department of Health.